NDC 21586-031-01 - CLAFORAN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 21586-031
- Requested NDC
- 21586-031-01
- Package NDCs from labels
- 21586-031-01, 21586-031-02
- Manufacturer
- SteriMax Inc. | Qilu Antibiotics Pharmaceutical Co., Ltd.
- Effective date
- 2026-08-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CLAFORAN - SteriMax Inc. | Qilu Antibiotics Pharmaceutical Co., Ltd. | SteriMax Inc. | Qilu Antibiotics Pharmaceutical Co., Ltd. | 2026-08-14 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefotaxime | CEFOTAXIME INJECTION | SteriMax Inc. | 8efe3bd0-c43a-2bd6-e053-2a95a90a92fa | 2026-06-15 | 258J72S7TZ | |
| Cefotaxime | CEFOTAXIME | Hikma Pharmaceuticals USA Inc. | ed23b6bc-32c7-4c50-a53d-313ae78e5623 | 2024-04-11 | Warnings, Adverse reactions | 258J72S7TZ |
| Cefotaxime | CEFOTAXIME | Hikma Pharmaceuticals USA Inc. | ef1a6dc6-bc3d-4f09-8f92-7ff328f56561 | 2024-04-11 | Warnings, Adverse reactions | 258J72S7TZ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.